Skip to main content

The Influence of Allopurinol on Renal Deterioration in Familial Nepropathy Associated with Hyperuricemia (FNAH)

  • Chapter
Purine and Pyrimidine Metabolism in Man VIII

Part of the book series: Advances in Experimental Medicine and Biology ((AEMB,volume 370))

Abstract

The kidney has been traditionally considered as one of the two primary target organs in gout (1), but long-term follow-up studies have failed to show a deleterious effect of gout on renal function (2). FNAH is characterized by hyperuricemia or gout, usually appearing at an early age and often in both sexes, associated with progressive renal failure (3–17). The pathogenesis of this syndrome is controversial. Some authors believe that renal deterioration is the result of sustained hyperuricemia because in some patients allopurinol halted the progression of renal insufficiency (8, 16). Most authors, however, have documented the progression of renal disease despite allopurinol therapy (7, 10, 11, 14, 15, 17). We examined the influence of allopurinol on the evolution of renal disease in patients with FNAH.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Talbott JH, Terplan KL. The kidney in gout. Medicine (Balt) 1960; 39:405–407.

    CAS  Google Scholar 

  2. Berger L, Yü T-F. Renal function in gout. IV. An analysis of 524 gouty subjects including long-term follow-up studies. Am J Med 1975; 59:605–613.

    Article  PubMed  CAS  Google Scholar 

  3. Duncan H, Dixon AS. Gout, familial hyperuricemia, and renal disease. Q J Med 1960; 29:127–135.

    PubMed  CAS  Google Scholar 

  4. Rosenbloom FM, Kelley WN, Carr AA, Seegmiller JE. Familial nephropathy and gout in a kindred (abstract). Clin Res 1967; 15:270.

    Google Scholar 

  5. Treadwell BU. Juvenile gout. Ann Rheum Dis 1971; 30:279–284.

    Article  PubMed  CAS  Google Scholar 

  6. Van Goor W, Kooiker CJ, Mees EJD. An unusual form of renal disease associated with gout and hypertension. J Clin Path 1971; 24:354–359.

    Article  PubMed  Google Scholar 

  7. Massari PU, Hsu CH, Barnes RV, Fox IH, Gikas PW, Weller JM. Familial hyperuricemia and renal disease. Arch Intern Med 1980; 140:680–684.

    Article  PubMed  CAS  Google Scholar 

  8. Simmonds HA, Warren DJ, Cameron JS, Potter CF, Farebrother DA. Familial gout and renal failure in young women. Clin Nephrol 1980; 14:176–182.

    PubMed  CAS  Google Scholar 

  9. Farebrother DA, Pincott JR, Simmonds HA, Warren DJ, Dillon MJ, Cameron JS. Uric acid crystal-induced nephropathy: Evidence for a specific renal lesion in a gouty family. J Pathol 1981; 135:159–168.

    Article  PubMed  CAS  Google Scholar 

  10. Richmond JM, Kincaid-Smith P, Whitworth JA, Becker GJ. Familial urate nephropathy. Clin Nephrol 1981; 16:163–168.

    PubMed  CAS  Google Scholar 

  11. Leumann EP, Wegmann W. Familial nephropathy with hyperuricemia and gout. Nephron 1983; 34:51–57.

    Article  PubMed  CAS  Google Scholar 

  12. Fleckenstein JL, Simkin PA. Corrected clearance identifies underexcretion of uric acid in a gouty kindred. Adv Exp Med Biol 1986; 195A:295–297.

    Article  Google Scholar 

  13. Calabrese G, Simmonds HA, Cameron JS, Davies PM. Precocious familial gout with reduced fractional urate clearance and normal purine enzymes. Q J Med 1990; 75:441–450.

    PubMed  CAS  Google Scholar 

  14. Murakami T, Kawakami H, Nakatsuka K, Jojima K, Nohno H, Matsuzaki H. Underexcretory-type hyperuricemia, disproportionate to the reduced glomerular filtration rate in two boys with mild proteinuria. Nephron 1990; 56:439–442.

    Article  PubMed  CAS  Google Scholar 

  15. Yokota N, Yamanaka H, Yamamoto Y, Fujimoto S, Eto T, Tanaka K. Autosomal dominant transmission of gouty arthritis with renal disease in a large Japanese family. Ann Rheum Dis 1991; 50:108–111.

    Article  PubMed  CAS  Google Scholar 

  16. Moro F, Ogg C, Simmonds HA, et al. Familial juvenile gouty nephropathy with renal urate hypoexcretion preceding renal damage. Clin Nephrol. 1991;35:263–269.

    PubMed  CAS  Google Scholar 

  17. Puig JG, Miranda ME, Mateos FA, Picazo ML, Jiménez ML, Calvin TS, Gil AA. Hereditary nephropathy associated with hyperuricemia and gout. Arch Intern Med 1993; 153: 357–365.

    Article  PubMed  CAS  Google Scholar 

  18. Beck LH. Requiem for gouty nephropathy. Kidney Int 1986; 30:280–287.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1995 Springer Science+Business Media New York

About this chapter

Cite this chapter

Miranda, M.E. (1995). The Influence of Allopurinol on Renal Deterioration in Familial Nepropathy Associated with Hyperuricemia (FNAH). In: Sahota, A., Taylor, M.W. (eds) Purine and Pyrimidine Metabolism in Man VIII. Advances in Experimental Medicine and Biology, vol 370. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-2584-4_15

Download citation

  • DOI: https://doi.org/10.1007/978-1-4615-2584-4_15

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4613-6105-3

  • Online ISBN: 978-1-4615-2584-4

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics